Fidelity Investments’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $84.7M | Buy |
4,544,188
+61,579
| +1% | +$1.15M | ﹤0.01% | 1187 |
|
|
2025
Q1 | $81.3M | Buy |
4,482,609
+43,328
| +1% | +$786K | 0.01% | 1175 |
|
|
2024
Q4 | $96.8M | Buy |
4,439,281
+36,133
| +0.8% | +$788K | 0.01% | 1135 |
|
|
2024
Q3 | $121M | Buy |
4,403,148
+728
| +0% | +$19.9K | 0.01% | 1022 |
|
|
2024
Q2 | $114M | Buy |
4,402,420
+241,375
| +6% | +$6.25M | 0.01% | 1000 |
|
|
2024
Q1 | $125M | Buy |
4,161,045
+1,942,833
| +88% | +$58.3M | 0.01% | 972 |
|
|
2023
Q4 | $22.6M | Hold |
2,218,212
| – | – | ﹤0.01% | 1581 |
|
|
2023
Q3 | $29M | Buy |
+2,218,212
| New | +$29M | ﹤0.01% | 1456 |
|
|
2023
Q2 | – | Sell |
-16
| Closed | -$202 | – | 5418 |
|
|
2023
Q1 | $202 | Buy |
+16
| New | +$202 | ﹤0.01% | 4851 |
|
|
2022
Q4 | – | Sell |
-36
| Closed | -$1K | – | 5396 |
|
|
2022
Q3 | $1K | Sell |
36
-12
| -25% | -$333 | ﹤0.01% | 4646 |
|
|
2022
Q2 | $1K | Buy |
48
+16
| +50% | +$333 | ﹤0.01% | 4692 |
|
|
2022
Q1 | $1K | Sell |
32
-46,537
| -100% | -$1.45M | ﹤0.01% | 4776 |
|
|
2021
Q4 | $3.3M | Hold |
46,569
| – | – | ﹤0.01% | 2458 |
|
|
2021
Q3 | $5.42M | Hold |
46,569
| – | – | ﹤0.01% | 2340 |
|
|
2021
Q2 | $7.29M | Buy |
46,569
+4,550
| +11% | +$712K | ﹤0.01% | 2219 |
|
|
2021
Q1 | $7.96M | Buy |
42,019
+35,931
| +590% | +$6.81M | ﹤0.01% | 2121 |
|
|
2020
Q4 | $764K | Hold |
6,088
| – | – | ﹤0.01% | 2573 |
|
|
2020
Q3 | $662K | Hold |
6,088
| – | – | ﹤0.01% | 2483 |
|
|
2020
Q2 | $731K | Sell |
6,088
-2,544
| -29% | -$305K | ﹤0.01% | 2448 |
|
|
2020
Q1 | $867K | Hold |
8,632
| – | – | ﹤0.01% | 2349 |
|
|
2019
Q4 | $2.09M | Hold |
8,632
| – | – | ﹤0.01% | 2242 |
|
|
2019
Q3 | $1.42M | Buy |
8,632
+988
| +13% | +$162K | ﹤0.01% | 2360 |
|
|
2019
Q2 | $1.8M | Buy |
+7,644
| New | +$1.8M | ﹤0.01% | 2352 |
|